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In 2004, Sinnreich et al. reported 15 subjects with a pure sensory disorder of peripheral 
origin, with no electrophysiologic sensory correlate on conventional nerve conduction studies 
[1]. These patients presented with severe sensory ataxia and functional impairment. The site 
of the lesion was presumed to be proximal to the dorsal root ganglion and this was supported 
by abnormal sensory evoked potentials (SSEPs) and normal central nervous system MRI 
(magnetic resonance imaging) in all, as well as by MRI abnormalities affecting the dorsal 
sensory rootlets, in 5 of the 15 patients. Cerebrospinal fluid protein was elevated in 13. 
Neuropathologic studies of biopsied sensory rootlets showed inflammatory changes in 3. 
Importantly, treatment with corticosteroids or intravenous immunoglobulin proved effective 
in 6 in improving function, with 4 returning to normal ambulation. They coined the disorder 
“CISP”, for “chronic immune sensory polyradiculopathy”. 
In the current issue of Muscle & Nerve, Khadilkar et al. report on 8 further patients with 
CISP, its postulated motor counterpart, and a mixed sensorimotor form [2]. They propose as a 
result, new terminology to describe the predominant system involved in these “chronic 
immune polyradiculopathies”. Two of their patients had CISP, 2 had the motor variant and 4 
had a sensorimotor form. Of interest, all patients displayed absent lower limb F-responses, 
except one, in whom they were impersistent. SSEPs were abnormal in all and CSF protein 
was raised in all. MRI, performed in all 8 subjects, demonstrated thickening and contrast 
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enhancement of the lumbosacral roots in all. Every patient responded to corticosteroids and 
immunosuppressants as assessed by the Modified Rankin scale. 
Their series is of great interest in the setting of the increasing complexity of the chronic 
inflammatory demyelinating polyneuropathy (CIDP) spectrum, but at the same time also 
represents a useful opportunity to re-visit the specific entity which has been described as 
represented by these polyradiculopathies, although to date in only a small number of 
published reports. This is important because, on the one hand, splitting these from CIDP 
means those patients should be considered as harboring different disorders, implying, 
suddenly, that only anecdotal evidence would exist to support their treatment modalities, as 
opposed to the strong evidence available for CIDP. This obviously, in practice, would prove 
unhelpful for patients and their treating neurologists, especially in view of the increasingly 
regulated availability of immunoglobulins worldwide. On the other hand, lumping them with 
CIDP may be understandably debatable, as these patients do not display motor 
demyelination, and in CISP, any peripheral electrophysiological abnormality whatsoever.  
There have been few published descriptions of “chronic immune polyradiculopathies” since 
Sinnreich’s initial paper. Experience from clinicians in centers with expertise in dysimmune 
neuropathies indicates these are very rare, but encountered, sometimes in what could be 
considered as somewhat even more atypical forms, with additional associated features [3-5]. 
The presence of sensory ataxia clinically, with areflexia and normal motor function, is for the 
neurologist, a red flag. This may or may not be supported by the above-mentioned tests, after 
overcoming the initial surprise of entirely normal conventional motor and especially, sensory 
electrophysiology. This infrequently encountered syndrome being potentially severely 
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disabling, but treatable, the question of using corticosteroids, and if contraindicated or 
ineffective, intravenous immunoglobulin or plasma exchanges, and in persistent refractory 
cases, even immunosuppression, is posed. Thus, CISP was classified as an atypical CIDP 
variant within the spectrum of CIDP in the European Federation of Neurological 
Societies/Peripheral Nerve Society (EFNS/PNS) 2010 Guidelines [6]. However, although 
clinically compatible with a sensory ataxic, and therefore atypical, CIDP, CISP does not meet 
electrophysiological requirements for the disorder. Furthermore, CSF protein elevation may 
be inconstant and recent data indicates the need for age-based cut-offs to define abnormal 
values, increasing uncertainty about its diagnostic value in the setting of additional 
suboptimal specificity [7]. Nerve MRI in the setting of immune-mediated neuropathy also 
poses problems of its own, especially given its recently confirmed low inter-rater reliability 
[8]. As regards SSEPs, their value is uncertain as specificity may be an issue, due to multiple 
other potential causes of undetectable responses and their lack of localizing value. Pathologic 
studies as described in the original paper are seldom possible in practice in most units as they 
require an invasive lumbar root biopsy with specialized peripheral nerve neuropathology. 
Hence, the diagnosis of CISP is not straightforward and reliance on the presence of clinical 
sensory ataxia with normal sensory conduction nerve conduction studies remains paramount.  
A first case of a postulated pure motor variant of CISP, labelled “CIMP” for “chronic 
immune demyelinating motor polyradiculopathy” was described by O’Ferrall et al. in 2013 
[9]. Their patient presented with back pain and progressive, pure motor weakness of the 
proximal and distal lower limbs over 10 years. Electrophysiology showed reduced fibular 
motor amplitudes with absent fibular and, of note, prolonged tibial F-responses. No other 
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conduction abnormality was present, including on sensory studies. EMG revealed multi-
myotomal acute and chronic denervation in lower limb muscles. Genetic studies excluded a 
PMP22 duplication. MRI demonstrated a thickened and contrast-enhancing cauda equina and 
CSF protein was elevated. A fascicular nerve root biopsy was performed and revealed 
numerous onion bulbs and loss of myelinated fibers but no inflammatory infiltrates. The 
patient failed a trial of immunoglobulins and corticosteroids but responded to plasma 
exchanges. 
The first sensorimotor description of “chronic immune polyradiculopathy” dates back to 
2017, also by Dr. Khadilkar’s group, who reported exclusively proximal lower limb 
weakness in one, proximal as well as distal lower limb weakness in the other, but upper limb 
sparing in both [10]. Reflexes were absent only in the legs. Proprioceptive involvement was 
marked in both patients, but again sparing the upper limbs. Electrophysiology showed normal 
sensory studies, with motor studies showing no abnormality, except absent/impersistent F-
waves affecting lower limb nerves only. SSEPs showed absent lumbar root potentials and 
delayed or absent cortical potentials from tibial nerve stimulations. CSF protein was raised in 
both and MRI showed contrast enhancement and thickening of the lumbosacral roots in one 
patient. Both patients responded favorably to corticosteroids and immunosuppressants with 
significant improvements in Modified Rankin scores. They termed the disorder “chronic 
immune sensorimotor polyradiculopathy” (“CISMP”). A further 9 patients with postulated 
“CISMP” were described by Thammongkolchai et al. in 2019, with what the authors 
described as clinically “classic CIDP” but electrophysiological findings of pure 
polyradiculopathy for which structural, infectious or neoplastic processes had been excluded 
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[11]. All had weakness, but, importantly, proximal only in 4, and with, interestingly, 
exclusive cranial involvement in one. Sensory symptoms were present in all but ataxia was 
clearly present only in one. Lower limb areflexia was present in all and cranial nerve 
dysfunction in 3. Electrophysiology showed preserved sensory conduction studies. Motor 
amplitudes were on the whole, normal, with no evidence of demyelination. However, F-
waves, performed in only one ulnar and one tibial nerve, notably showed likely 
demyelinating-range prolongation of latencies in 4/9, moderate prolongation in 2/9 and 
absence in 1/9. Multi-myotomal lower limb active and chronic denervation was present in all 
subjects. Further investigations showed elevated CSF protein in 8/9 and contrast 
enhancement of the lumbosacral nerve roots in 8/9, with 5/9 exhibiting root thickening. With 
corticosteroids, immunoglobulins and immunosuppressants, alone or in combination, all 
equally displayed improvement on the Modified Rankin scale.  
One of the main issues with these “chronic immune polyradiculopathies” relates to the extent 
of distal nerve segment preservation from inflammatory demyelination. Of relevance, we 
reported a patient with a CISP phenotype, but who displayed some limited degree of post-
ganglionic sensory electrophysiological involvement, while meeting all other criteria for 
CISP and responding remarkably to immunoglobulin treatment, after corticosteroid-induced 
deterioration [4]. Some spreading of the pathologic process beyond the dorsal root ganglion 
adds the word “neuropathy” to “chronic immune polyradiculopathy”, and if this involves 
motor fibres with slowed conductions, the word “demyelinating”, also comes into play, 
making it, potentially, simply, “CIDP”. The description of “chronic immune 
polyradiculopathy” appears hence purely anatomical, with an overreliance on the ability of 
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electrophysiology to precisely localize. CIDP is known to affect nerves in a patchy manner 
and heterogeneous clinical as well as electrophysiological presentations are as a result, 
unsurprisingly. A second important question is how far we go to demonstrate inflammatory 
demyelination electrophysiologically. Simply and intuitively, less extensive testing is less 
likely to achieve the diagnosis, as we previously showed [12]. It is otherwise equally 
unsurprising that distal motor latencies and motor conduction velocities are normal when the 
pathology is proximal, just as are the absence of conduction block and temporal dispersion. 
However, as described in Khadilkar et al.’s current series [2], F-wave abnormalities are 
indicative of motor root pathology even in absence of clinical weakness, in many of these 
patients. It is noteworthy that the European Federation of Neurological Societies/Peripheral 
Nerve Society (EFNS/PNS) Guidelines considers both F-wave prolongation and absence as 
part of the electrodiagnostic criteria for CIDP [6]. Several described subjects had such 
abnormalities, but the studies, as detailed, were of limited extensiveness, a known reason for 
electrophysiological underdiagnosis of CIDP [12, 13]. This, as a result, makes them 
inconclusive instead of allowing, as postulated, the exclusion of CIDP. In addition, it is 
known that pure inflammatory sensory neuropathic disease may present with asymptomatic 
proximal segment motor abnormalities, including conduction blocks [3], as we have also 
found in our experience [14]. These were not sought for in any of the above-mentioned 
reports. Regarding the stated MRI findings, as opposed to Sinnreich et al.’s initial paper 
which described exclusive sensory rootlet abnormalities, subsequent reports all demonstrate 
post-ganglionic segment changes, consistent with what is reported in CIDP, albeit with the 
limitations of the MRI technique.  
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What could one therefore conclude about the concept of the “chronic immune 
polyradiculopathies” for clinical practice? The published descriptions certainly add to 
knowledge in the field in relation to phenotype variability, but going back to the basics, the 
clinical presentation can be sensory, motor or sensorimotor, and thus, remarkably reminiscent 
of sensory, motor and sensorimotor CIDP. The frequent lower limb-exclusive presentation in 
the published series is reminiscent of the lumbosacral CIDP variant described by Caporale et 
al. [15], representing a focal form of the disorder, also already clearly within EFNS/PNS 
criteria of 2010, as a form of “atypical” CIDP [6]. In addition, several of the reported patients 
had other features such as exclusively distal weakness or cranial nerve involvement, again 
suggesting they form part of the established variants of “atypical” CIDP. The 
electrophysiology in the published reports, finally and importantly, clearly indicates 
insufficient testing, not only in the number of nerves studied and the stimulation sites (none 
had bilateral 8-nerve studies or proximal upper limb nerve stimulations up to Erb’s point [12, 
16]), but also in that of the considered parameters (distal compound muscle action potential 
durations, for example, although of substantial diagnostic value for CIDP [17, 18], were 
absent from all reports). Although unfortunately common in practice, this is evidently 
problematic here in justifying the concept of an entity separate from CIDP. 
The CIDP field is evolving and the newly-described antiparanodal antibody positive cases 
well-illustrate this [19]. The pathology in such cases is neither inflammatory nor 
demyelinating, the treatment likely to be different, and this may suggest they should be 
considered separately [20]. As regards the “chronic immune polyradiculopathies” however, 
given the clinical picture, the available albeit limited pathologic data, the absence of certainty 
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of non-fulfilment of EFNS/PNS electrophysiological criteria, and the reported response to 
conventional treatments, such a need for separation is difficult to justify. The EFNS/PNS 
CIDP Guidelines and criteria require revision and this process, already under way, will 
hopefully be successful in helping and simplifying the diagnostic process of what is an 
increasingly heterogeneous disorder. Lumping rather than further splitting, on this occasion, 
requires careful consideration. On this may depend easing the diagnosis and access to 
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